Company Analysis VYNE Therapeutics Inc.
1. Summary
Advantages
- Price (0.3733 $) is less than fair price (1.18 $)
- Current debt level 0.148% is below 100% and has decreased over 5 years from 0.8838%.
Disadvantages
- Dividends (0%) are below the sector average (0.5335%).
- The stock's return over the last year (-79.49%) is lower than the sector average (-45.36%).
- The company's current efficiency (ROE=-56.57%) is lower than the sector average (ROE=103.63%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| VYNE Therapeutics Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -1.2% | -50% | -0.1% |
| 90 days | -74.3% | -43.6% | 13.8% |
| 1 year | -79.5% | -45.4% | 29.4% |
VYNE vs Sector: VYNE Therapeutics Inc. has significantly underperformed the "Healthcare" sector by -34.13% over the past year.
VYNE vs Market: VYNE Therapeutics Inc. has significantly underperformed the market by -108.93% over the past year.
Slightly volatile price: VYNE is more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: VYNE with weekly volatility of -1.53% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (0.3733 $) is lower than the fair price (1.18 $).
Price significantly below the fair price: The current price (0.3733 $) is 216.1% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-0.3715) is higher than that of the sector as a whole (-274.25).
P/E vs Market: The company's P/E (-0.3715) is higher than that of the market as a whole (-78.44).
5.3. P/BV
P/BV vs Sector: The company's P/BV (2.61) is lower than that of the sector as a whole (256.7).
P/BV vs Market: The company's P/BV (2.61) is lower than that of the market as a whole (51.48).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (271.18) is higher than that of the sector as a whole (56.99).
P/S vs Market: The company's P/S indicator (271.18) is higher than that of the market as a whole (136.11).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-2.66) is lower than that of the sector as a whole (12.51).
EV/Ebitda vs Market: The company's EV/Ebitda (-2.66) is higher than that of the market as a whole (-46.89).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -16.88% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-16.88%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-22.73%).
6.4. ROE
ROE vs Sector: The company's ROE (-56.57%) is lower than that of the sector as a whole (103.63%).
ROE vs Market: The company's ROE (-56.57%) is lower than that of the market as a whole (-10.11%).
6.6. ROA
ROA vs Sector: The company's ROA (-48.4%) is lower than that of the sector as a whole (-2.84%).
ROA vs Market: The company's ROA (-48.4%) is lower than that of the market as a whole (39.27%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (-111.75%) is lower than that of the sector as a whole (1.17%).
ROIC vs Market: The company's ROIC (-111.75%) is lower than that of the market as a whole (8.7%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5335%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
